Athens 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings
ATHENS escrs

Analysis of optical purity and optical quality of a new extended range of vision IOL

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Session Details

Session Title: Cataract I
Session Date/Time: Friday 26/02/2016 | 10:30-12:30
Paper Time: 10:42
Venue: MC3 Room
First Author: : G.Auffarth GERMANY
Co Author(s): :    P. Merz   S. Liebing   T. Tandogan   E. Friedmann   T. Rabsilber  

Abstract Details

Purpose:

To assess the optical biomaterial purity of a hydrophobic acrylic foldable EROV intraocular lens regarding fluid filled microvacuoles (glistenings) and to test the optical quality using an optical bench system.

Setting:

The David J Apple International Laboratory for Ocular Pathology and International Vision Correction Research Centre (IVCRC), Department of Ophthalmology, University of Heidelberg, Heidelberg, Germany

Methods:

Glistening development has been induced artificially in the lab using the TECNIS® Symfony IOL (AMO) compared to the AcrySof® IQ PanOptix® IOL (Alcon) by immersing the lenses in water at 45°C for 24h with subsequent incubation at 37°C for 2.5h. Severity grade of glistenings is calculated according to the Miyata scale. Optical analysis of the TECNIS® Symfony IOL (AMO) was carried out in water using the spectrophotometer (OptiSpheric IOL, Trioptics) at three different apertures to determine modulation transfer function (MTF) and relative light transmission.

Results:

Optical bench analysis showed an extended range of vision for the TECNIS® Symfony IOL (AMO) combined with good optical biomaterial purity.

Conclusions:

TECNIS® Symfony IOL (AMO) is a new extended range of vision IOL on the market with excellent optical material and optical quality performance.

Financial Disclosure:

One or more of the authors receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, One or more of the authors travel has been funded, fully or partially, by a competing company, One or more of the authors travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, One or more of the authors research is funded, fully or partially, by a competing company, One or more of the authors research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, One or more of the authors receives consulting fees, retainer, or contract payments from a competing company

Back to previous